Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-27

Clinical Trial Update: A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced/Recurrent Gastric Cancer

View source ↗

Summary

A clinical trial update on the effectiveness and safety of Nivolumab plus chemotherapy for patients with untreated advanced or recurrent gastric cancer; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Stomach Neoplasms | Status: ACTIVE_NOT_RECRUITING